There will be a huge impact to ARIA share price once Pona to be moved from 4th to 3rd (or 2nd) line drug. The Japan approval today definitely helps increasing that possibility.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.